Medtronic Inc (MDT) 70.94 $MDT
Medtronic (MDT) Acquires Twelve to Foray into TMVR Market
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 1:25PM CDT
Medtronic Inc. (MDT) recently completed its earlier-declared acquisition of California-based medical device start-up firm, Twelve, Inc.
ICUI: 106.89 (+1.05), MDT: 70.94 (+1.02), BAX: 32.91 (+0.64), NUVA: 52.21 (+0.14)
Medtronic (MDT) Valiant Thoracic Stent Graft Results Impress
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 12:10PM CDT
Medtronic's (MDT) Valiant Thoracic Stent Grafting System allows physicians to offer innovative and minimally invasive treatment to thoracic aortic aneurysm patients.
ICUI: 106.89 (+1.05), MDT: 70.94 (+1.02), ENZY: 9.67 (+0.34), NUVA: 52.21 (+0.14)
2 ETFs Rising to Rank #1 This Earnings Season
Sweta Killa - Zacks Investment Research - Wed Oct 07, 9:15AM CDT
A couple of sector ETFs have seen their Ranks surging to the top hierarchy and could be the winners this earnings season.
ABT: 40.63 (+0.74), MDT: 70.94 (+1.02), ORLY: 251.78 (-2.01), IHI: 113.65 (+1.43), PEZ: 46.12 (+0.23)
Global Diabetes Care Devices Market Outlook 2015-2020 - Market is Expected to Grow at a CAGR of 5.2%
M2 - Wed Oct 07, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jb8dxs/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Outlook: 2015-2020" report to their offering. The global diabetes care devices market is expected to grow at a CAGR of 5.2% from 2015 to 2020 to reach $24.6 billion by 2020 This market is mainly driven by increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet, and increasing need for faster and safer diagnosis and treatment of diabetes. Furthermore, huge investments by the market leaders and foraying of new companies into this market, wide scope of penetration in untapped and emerging markets, and rising awareness among people about diabetes care are also accelerating the growth of this market. However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies, lack of awareness, strict regulatory obligations, and high cost of diabetic food hinders the growth of this market to some extent. The research report on the diabetes care devices market provides comprehensive analysis of the global market with a country level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major product segments such as diabetes control solutions, diabetes monitoring devices, and insulin delivery devices. The diabetes monitoring devices segment further sub-segmented into continuous blood glucose monitoring devices, test strips, lancets, and hemoglobin A1c (HbA1c) testing kits. The insulin delivery devices further sub-segmented into insulin syringes, insulin pens, insulin pumps, and insulin injectors. Key Topics Covered: 1 Introduction to Diabetes Care Devices Market 2 Executive Summary 3 Market Insights 4 Global Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Product Type 5 Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Geography 6 Global Diabetes Care Devices Market- Competitive Landscape 7 Company Profiles - ARKRAY Inc. - Abbott Laboratories - Bayer HealthCare AG - Becton, Dickinson and Company - Dexcom, Inc. - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Johnson & Johnson - Medtronic, Inc. - Novo Nordisk A/S - Sanofi S.A - Tandem Diabetes Care, Inc - Terumo Corporation - Ypsomed AG For more information visit http://www.researchandmarkets.com/research/jb...l_diabetes
JNJ: 94.98 (+1.56), ABT: 40.63 (+0.74), NVO: 54.60 (-0.59), MDT: 70.94 (+1.02), LLY: 83.99 (-0.18)
IMPACT 2030 Rallies Global Corporations to Help Achieve the Sustainable Development Goals Through Corporate Volunteer Efforts
PR Newswire - Wed Oct 07, 5:00AM CDT
Corporations around the world are banding together with IMPACT 2030 and mobilizing their corporate volunteers to help combat the most critical issues that our world faces, including poverty, inequality and climate change. In advance of the United Nation's adoption of the Post-2015 Sustainable Development Goals (SDGs), fourteen global companies founded IMPACT 2030, a business-led coalition that aligns companies and their employee volunteer efforts with the newly-launched Sustainable Development Goals to address the needs of our rapidly changing world and create real and sustainable change. The growing network of businesses already includes: IBM, SAP, Google, GSK, TATA Consultancy Services, The Dow Chemical Company, Medtronic, and The Ritz-Carlton, amongst others.
MDT: 70.94 (+1.02), IBM: 150.09 (+1.31)
Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015
Thomson Reuters ONE - Tue Oct 06, 11:30AM CDT
Meeting Highlights New Two-Year Data on IN.PACT Admiral DCB, First Report of Real-World TVT Registry with CoreValve System, First One-Year Data on Recapturable Evolut R, and Initial Results on First Implants of Drug-Filled Stent
MDT: 70.94 (+1.02)
Engaged Capital Pressures HeartWare to Drop Valtech Deal
at The Street - Tue Oct 06, 9:11AM CDT
The activist investor is calling for the end of the proposed $860 million deal, vowing to campaign against it and seek board seats if its advice goes unheeded.
BSX: 16.82 (+0.25), ABT: 40.63 (+0.74), JNJ: 94.98 (+1.56), BDX: 137.24 (+2.65), ZBH: 94.89 (+0.90), MDT: 70.94 (+1.02), STJ: 63.10 (+0.62), HTWR: 54.41 (+2.10)
Global Energy-based Therapeutics Market - Industry Analysis 2015-2019: Key Vendors are Johnson & Johnson, Lumenis & Syneron Medical
M2 - Tue Oct 06, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2jl9cl/global) has announced the addition of the "Global Energy-based Therapeutics Market - Industry analysis 2015-2019" report to their offering. The global energy-based therapeutics market to grow at a CAGR of 7.30% over the period 2014-2019. Energy-based therapeutics involves the use of energy fields. These therapies include technologies such as microwave, radiofrequency, hydro-mechanical, cryotherapy, thermal, and ultrasound, which are used for either treatment or destruction of tissues to remove pathology. Energy-based therapies work on the mechanism of altering energy fields around patient's body, which can initiate healing and wellness. The report includes the present scenario and the growth prospects of the global energy-based therapeutics market for 2015-2019. The market can be segmented into clinical applications: general surgery, ophthalmic, and aesthetic. A major trend is in the rising popularity of physician-owned ambulatory surgical centers (ASCs). Since most energy-based procedures do not necessarily require hospital stays, surgeons have started performing minimally invasive surgeries in ambulatory centers. The reimbursements provided in these outpatient settings encourage doctors to perform energy-based procedures in their own ASCs. According to the report, the increasing demand for aesthetic surgeries is a major driver contributing to the market growth. There has been a rise in the demand for high-quality and affordable cosmetic surgical procedures such as non-invasive aesthetic treatments. Further, the report states that the varied regulations for medical devices are among the major challenges faced by the market during the forecast period. Key Vendors - Johnson & Johnson - Lumenis - Syneron Medical Other Prominent Vendors - Abbott Medical Optics - Alcon - Alna Medical System - Angiodynamic - AngioDynamics - AtriCure - biolitec - Boston Scientific - Bovie Medical - Cardiogenesis - Cutera - Cynosure - Dornier MedTech - Ellex - InSightec - IRIDEX - Lightmed - Mederi Therapeutics - Medtronic - Optos - Photocure - PhotoMedex - Quantel Medical - Radiancy - Schwind - Sichuan Jinjiang Electronic Science and Technology - SonaCare Medical - StarMedTec - Ziemer Ophthalmic Systems For more information visit http://www.researchandmarkets.com/research/2jl9cl/global
ELOS: 7.94 (+0.23), BSX: 16.82 (+0.25), JNJ: 94.98 (+1.56), MDT: 70.94 (+1.02), PHMD: 0.52 (+0.06), BVX: 2.10 (+0.21)
Medtronic's Verify System Wins FDA Expanded Use Approval
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 1:55PM CDT
Medtronic (MDT) is the only known company which manufactures devices like Interstim and Verify systems that facilitate sacral neurostimulator
ICUI: 106.89 (+1.05), NSTG: 15.81 (+0.45), MDT: 70.94 (+1.02), OSUR: 4.59 (+0.09)
Global Bone Grafts and Substitutes 2015-2019 - Demand for Orthopedic Biomaterials
M2 - Mon Oct 05, 9:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gvqp59/global_bone) has announced the addition of the "Global Bone Grafts and Substitutes 2015-2019" report to their offering. The global bone graft and substitute market to grow at a CAGR of 4.31% over the period 2014-2019. Based on type, the global bone graft and substitute market can be segmented into BMP, machine bone allograft, DBM, standard allograft, and others. BMP is beneficial in spinal fusion, joint reconstruction, bone fractures, and bone defects. It also eliminates the need for transplantation of bone from other areas of the body, such as the pelvis. Machine bone allograft uses innovative technology to reshape or mold donor grafts. The report, Global Bone Graft and Substitute Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global bone graft and substitute market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market. In addition to the surging aging population, the incidence rates of osteoarthritis and other types of degenerative disorders are also expected to grow in the future, which will drive the demand for orthopedic biomaterials bone grafts. According to the report, Growing demand for MIS, biologics, and instrumentation has led to more reliable spinal fusion and has reduced patient morbidity. Degeneration of bones and joints, brought about by aging leads to instability and stenosis. This has increased the demand for spinal fusion and joint reconstruction. Further, the report states that the high cost involved in bone grafting surgeries, coupled with inadequate medical reimbursement policies, is affecting the growth of the global bone graft and substitute market. Key vendors - DePuy Synthes - Medtronic - Stryker - Wright Medical Technology - Zimmer Dental Other prominent vendors - AlloSource - Alphatec Spine - Arthrex - Atrium Medical - B. Braun Melsungen - Bacterin International Holdings - Berkeley Advanced Materials - BioMimetic Therapeutics - Cryolife - Exactech - Globus Medical - Graftys SAS - Integra Life Sciences Holdings - Johnson and Johnson - LifeNet Health - Medtronic - Novabone Products - NuVasive - Olympus Biotech - Osteogenics Biomedical - RTI Surgical - Sanofi Aventis - Scient'x/Alphatec Spine - Smith & Nephew - Synthes - Tornier For more information visit http://www.researchandmarkets.com/research/gv...lobal_bone
SNN: 34.52 (-0.77), JNJ: 94.98 (+1.56), MDT: 70.94 (+1.02), GMED: 22.18 (+0.52)
Medtronic's Valiant(R) Thoracic Stent Graft System Demonstrates Durability After Five Years
Thomson Reuters ONE - Mon Oct 05, 8:00AM CDT
Valor II U.S. Study Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms
MDT: 70.94 (+1.02)
Global Radiofrequency Ablation Devices Market Assessment & Forecast: 2015-2019
M2 - Mon Oct 05, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kqtww5/global) has announced the addition of the "Global Radiofrequency Ablation Devices Market Assessment & Forecast: 2015-2019" report to their offering. The global RF ablation devices market is greatly influenced by the segment or application of devices. There are several players operating in multiple segments such as renal denervation, arthroscopy and pain management together. Acquisitions and mergers have further increased competition of companies and the market shows a trend of consolidation of core competencies in radiofrequency ablation technologies. RFA has become the image-guided minimally invasive technique of choice today due to its efficacy, safety, and ease of use. This procedure is also often reserved for patients with comorbidities and those who are inoperable for other reasons and one of the major driving factors for this technology is the fact that a large number of cases are treated as out-patient procedures reducing hospital stay and expenditure. Tumor management and cardiac rhythm management were the largest applications accounting for 60.3% of the market for RF devices across the world. In 2014, revenue generated from devices sold for tumor management across the world accounted for a share of 36.1%. Overall clinical applications of RF energy involve 3 major actions on the body; ablation of cancerous tissue, ablation of obstructive and excessive tissue, denervation or deadening of nerves. Approximately 750,000 new cases of liver cancer are diagnosed each year annually with more than 20,000 being in United States and around 5,000 in the United Kingdom. RF ablation presents one of the best treatment options for solid tumor in liver due to a lack of other alternatives. Lung cancer occurs in over 2.5 million people across the globe and is the leading cause of cancer death with an estimated 1.6 million deaths annually. Although a large percentage of patients are not eligible for surgery, a growing fraction of population is suitable for minimally invasive RF ablation procedure. Stryker offers RF ablation portfolio for both pain management and arthroscopy, similarly Medtronic Inc (and Covidien) together offer a large RF device portfolio targeting general surgery, renal denervation and tumor management. Major players in this market are Medtronic Inc, Johnson & Johnson, Boston Scientific, St. Jude Medical, Stryker, Arthrex, Haylard Health, Angiodynamics, AtriCure, Sutter and Smith & Nephew. Overall the market is quite fragmented and the industry continues to see consolidation in major therapeutic areas such as cardiac ablation and general surgery. Key Topics Covered: Chapter 1 Preface Chapter 2 Pr?cis Chapter 3 Market Dynamics Chapter 4 Radiofrequency Ablation Devices - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019 Chapter 5 Radiofrequency Ablation Devices - Global Market Size Assessment, by Products, Forecast: 2015 - 2019 Chapter 6 Radiofrequency Ablation Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019 Chapter 7 Key Players Analysis: Radiofrequency Ablation Devices Market Share, 2014 (%) Chapter 8 Epilogue Companies Mentioned - AngioDynamics - Arthrex - AtriCure Inc. - Biotronik - Boston Scientific Corporation - Cosman Medical Inc. - Diros Technology - Fcare Systems - Haylard Health Inc. - Hologic (Novasure) - Johnson & Johnson (Biosense Webster & DePuy Mitek) - Medtronic Inc (Covidien PLC) - St. Jude Medical - Stockert - Stryker - Stryker Corporation - Sutter Medizintechnik GmbHTopera (Abbott Laboratories) For more information visit http://www.researchandmarkets.com/research/kqtww5/global
BSX: 16.82 (+0.25), JNJ: 94.98 (+1.56), ABT: 40.63 (+0.74), MDT: 70.94 (+1.02), STJ: 63.10 (+0.62), ATRC: 18.41 (+0.15), HOLX: 37.48 (+0.01), SYK: 96.00 (+1.08)
Medtronic acquires Twelve for undisclosed sum
M2 - Mon Oct 05, 4:38AM CDT
Medical technology company Medtronic (NYSE:MDT) revealed on Friday that it has completed the acquisition of Twelve for an undisclosed value.
MDT: 70.94 (+1.02)
Medtronic Completes Acquisition of Twelve, Inc.
Thomson Reuters ONE - Fri Oct 02, 1:13PM CDT
DUBLIN - October 2, 2015 - Medtronic plc (NYSE: MDT) today announced that it has completed the acquisition of Twelve, Inc. ("Twelve"
, a privately-held medical device company based in Redwood City, CA, focused on the development of a transcatheter mitral valve replacement (TMVR) device.
MDT: 70.94 (+1.02)
Are Medtronic's Competitors Finally Catching Up?
Brian Feroldi, The Motley Fool - Motley Fool - Fri Oct 02, 9:47AM CDT
Medical device juggernaut Medtronic is a big player in the world of healthcare, and it holds strong competitive positions in a huge number of diseases including cardiac care, minimally invasive surgery, spinal surgery, and more. One division...
PODD: 29.79 (+1.02), DXCM: 78.66 (-1.46), MDT: 70.94 (+1.02), TNDM: 8.31 (-0.11)
Spinal Implants and Spinal Devices Market - Global Forecast to 2020: Thoracic, Lumbar, Cervical Fusion, Biologics, Motion Preservation, VCFs, Bone Stimulator
M2 - Fri Oct 02, 3:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l93t4t/spinal_implants) has announced the addition of the "Spinal Implants and Spinal Devices Market by Product, Technologies, Minimally Invasive Device & Decompression - Global Forecast to 2020" report to their offering. The market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020 Technological advancements in spine surgery devices, and increasing aging and obese population with increasing number of spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the spinal implants and spinal devices market. However, the stringent product approval process, uncertainty in reimbursement, and high cost of treatment procedures are some of the prime factors restraining the growth of this market. Furthermore, lack of adequate physician and patient awareness/education about newly developed treatment procedures and technologies and high pricing pressure on market players are other factors hampering market growth. Emerging markets, including China, India, South Korea, and Brazil are attractive markets for companies engaged in the development and distribution of spinal implants and spinal devices. Rising government healthcare expenditure, growing income levels, presence of a large patient population, and rising obesity cases in these countries are some of the key factors propelling the demand for spinal implants and spinal devices in these emerging markets. As of 2014, Medtronic, plc (U.S.) held the leadership position in the global spinal implants and spinal devices market. Over the past three years, the company adopted product innovation and new product launches as its key business strategy to ensure its dominance in this market. DePuy Synthes (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V. (Netherlands), K2M Group Holdings, Inc. (U.S.), LDR Holding Corporation (U.S.) are some of the other key players in this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Spinal Implants and Spinal Devices Market, By Product 7 Spinal Implants and Spinal Devices Market, By Technology 8 Spinal Implants and Spinal Devices Market, By Type of Surgery 9 Spinal Decompression Devices Market, By Type of Procedure 10 Spinal Implants and Spinal Devices Market, By Region 11 Competitive Landscape 12 Company Profiles - Alphatec Spine Inc. - Depuy Synthes - Globus Medical, Inc. - K2M Group Holdings, Inc. - Medtronic, PLC - Nuvasive, Inc. - Orthofix International N.V. - Stryker Corporation - Zimmer Biomet Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/l9...l_implants
ATEC: 0.33 (-0.01), ZBH: 94.89 (+0.90), LDRH: 36.98 (+0.84), MDT: 70.94 (+1.02), GMED: 22.18 (+0.52), OFIX: 33.18 (+0.05), NUVA: 52.21 (+0.14), KTWO: 19.83 (-0.25), SYK: 96.00 (+1.08)
Research and Markets: Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis Featuring Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter International
Business Wire - Fri Oct 02, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2h7sm/global_medical) has announced the addition of the "Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis" report to their offering.
JNJ: 94.98 (+1.56), GE: 27.77 (+0.48), MDT: 70.94 (+1.02)
Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis Featuring Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter Internationa
M2 - Fri Oct 02, 3:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/488wjw/global_medical) has announced the addition of the "Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis" report to their offering. The global medical device market is expected to grow at a CAGR of 4.9% from 2015 to 2020. The major drivers of this market are increasing per capita income, availability of medical insurance, and increasing health-related infrastructure. Asia Pacific (APAC) is expected to lead the global medical device market. Technological advancement, growing population, and increasing health-related infrastructure are anticipated to drive the Asia Pacific market. The author has analyzed the global medical device market by region and has come up with a comprehensive research report, "Global Medical Device Market 2015-2020: Trend, Profit, and Forecast Analysis". This report provides an analysis of the global medical device market, including the market trends, growth opportunities, key drivers, and emerging trends in the market. Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter International Inc. are some of the major suppliers of medical devices to various customers of the industry. Key Topics Covered: 1. Executive Summary 2. Market Definition and Scope 3. Market Overview 4. Macroeconomic Trend 5. Market Trends 6. Competitive Landscape 7. Macroeconomic Forecast 8. Market Forecasts 9. Emerging Trends 10. Growth Opportunity 11. Conclusions For more information visit http://www.researchandmarkets.com/research/48...al_medical
JNJ: 94.98 (+1.56), GE: 27.77 (+0.48), MDT: 70.94 (+1.02)
Medtronic Set to Possibly Pullback After Yesterday's Rally of 2.18%
Comtex SmarTrend(R) - Thu Oct 01, 4:29PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $66.35 to a high of $68.48. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $68.01 on volume of 11.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 70.94 (+1.02)
Medtronic (MDT) Acquires Twelve to Foray into TMVR Market
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 1:25PM CDT
Medtronic Inc. (MDT) recently completed its earlier-declared acquisition of California-based medical device start-up firm, Twelve, Inc.
ICUI: 106.89 (+1.05), MDT: 70.94 (+1.02), BAX: 32.91 (+0.64), NUVA: 52.21 (+0.14)
Medtronic (MDT) Valiant Thoracic Stent Graft Results Impress
Zacks Equity Research - Zacks Investment Research - Wed Oct 07, 12:10PM CDT
Medtronic's (MDT) Valiant Thoracic Stent Grafting System allows physicians to offer innovative and minimally invasive treatment to thoracic aortic aneurysm patients.
ICUI: 106.89 (+1.05), MDT: 70.94 (+1.02), ENZY: 9.67 (+0.34), NUVA: 52.21 (+0.14)
2 ETFs Rising to Rank #1 This Earnings Season
Sweta Killa - Zacks Investment Research - Wed Oct 07, 9:15AM CDT
A couple of sector ETFs have seen their Ranks surging to the top hierarchy and could be the winners this earnings season.
ABT: 40.63 (+0.74), MDT: 70.94 (+1.02), ORLY: 251.78 (-2.01), IHI: 113.65 (+1.43), PEZ: 46.12 (+0.23)
Global Diabetes Care Devices Market Outlook 2015-2020 - Market is Expected to Grow at a CAGR of 5.2%
M2 - Wed Oct 07, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jb8dxs/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Outlook: 2015-2020" report to their offering. The global diabetes care devices market is expected to grow at a CAGR of 5.2% from 2015 to 2020 to reach $24.6 billion by 2020 This market is mainly driven by increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet, and increasing need for faster and safer diagnosis and treatment of diabetes. Furthermore, huge investments by the market leaders and foraying of new companies into this market, wide scope of penetration in untapped and emerging markets, and rising awareness among people about diabetes care are also accelerating the growth of this market. However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies, lack of awareness, strict regulatory obligations, and high cost of diabetic food hinders the growth of this market to some extent. The research report on the diabetes care devices market provides comprehensive analysis of the global market with a country level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major product segments such as diabetes control solutions, diabetes monitoring devices, and insulin delivery devices. The diabetes monitoring devices segment further sub-segmented into continuous blood glucose monitoring devices, test strips, lancets, and hemoglobin A1c (HbA1c) testing kits. The insulin delivery devices further sub-segmented into insulin syringes, insulin pens, insulin pumps, and insulin injectors. Key Topics Covered: 1 Introduction to Diabetes Care Devices Market 2 Executive Summary 3 Market Insights 4 Global Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Product Type 5 Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Geography 6 Global Diabetes Care Devices Market- Competitive Landscape 7 Company Profiles - ARKRAY Inc. - Abbott Laboratories - Bayer HealthCare AG - Becton, Dickinson and Company - Dexcom, Inc. - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Johnson & Johnson - Medtronic, Inc. - Novo Nordisk A/S - Sanofi S.A - Tandem Diabetes Care, Inc - Terumo Corporation - Ypsomed AG For more information visit http://www.researchandmarkets.com/research/jb...l_diabetes
JNJ: 94.98 (+1.56), ABT: 40.63 (+0.74), NVO: 54.60 (-0.59), MDT: 70.94 (+1.02), LLY: 83.99 (-0.18)
IMPACT 2030 Rallies Global Corporations to Help Achieve the Sustainable Development Goals Through Corporate Volunteer Efforts
PR Newswire - Wed Oct 07, 5:00AM CDT
Corporations around the world are banding together with IMPACT 2030 and mobilizing their corporate volunteers to help combat the most critical issues that our world faces, including poverty, inequality and climate change. In advance of the United Nation's adoption of the Post-2015 Sustainable Development Goals (SDGs), fourteen global companies founded IMPACT 2030, a business-led coalition that aligns companies and their employee volunteer efforts with the newly-launched Sustainable Development Goals to address the needs of our rapidly changing world and create real and sustainable change. The growing network of businesses already includes: IBM, SAP, Google, GSK, TATA Consultancy Services, The Dow Chemical Company, Medtronic, and The Ritz-Carlton, amongst others.
MDT: 70.94 (+1.02), IBM: 150.09 (+1.31)
Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015
Thomson Reuters ONE - Tue Oct 06, 11:30AM CDT
Meeting Highlights New Two-Year Data on IN.PACT Admiral DCB, First Report of Real-World TVT Registry with CoreValve System, First One-Year Data on Recapturable Evolut R, and Initial Results on First Implants of Drug-Filled Stent
MDT: 70.94 (+1.02)
Engaged Capital Pressures HeartWare to Drop Valtech Deal
at The Street - Tue Oct 06, 9:11AM CDT
The activist investor is calling for the end of the proposed $860 million deal, vowing to campaign against it and seek board seats if its advice goes unheeded.
BSX: 16.82 (+0.25), ABT: 40.63 (+0.74), JNJ: 94.98 (+1.56), BDX: 137.24 (+2.65), ZBH: 94.89 (+0.90), MDT: 70.94 (+1.02), STJ: 63.10 (+0.62), HTWR: 54.41 (+2.10)
Global Energy-based Therapeutics Market - Industry Analysis 2015-2019: Key Vendors are Johnson & Johnson, Lumenis & Syneron Medical
M2 - Tue Oct 06, 4:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2jl9cl/global) has announced the addition of the "Global Energy-based Therapeutics Market - Industry analysis 2015-2019" report to their offering. The global energy-based therapeutics market to grow at a CAGR of 7.30% over the period 2014-2019. Energy-based therapeutics involves the use of energy fields. These therapies include technologies such as microwave, radiofrequency, hydro-mechanical, cryotherapy, thermal, and ultrasound, which are used for either treatment or destruction of tissues to remove pathology. Energy-based therapies work on the mechanism of altering energy fields around patient's body, which can initiate healing and wellness. The report includes the present scenario and the growth prospects of the global energy-based therapeutics market for 2015-2019. The market can be segmented into clinical applications: general surgery, ophthalmic, and aesthetic. A major trend is in the rising popularity of physician-owned ambulatory surgical centers (ASCs). Since most energy-based procedures do not necessarily require hospital stays, surgeons have started performing minimally invasive surgeries in ambulatory centers. The reimbursements provided in these outpatient settings encourage doctors to perform energy-based procedures in their own ASCs. According to the report, the increasing demand for aesthetic surgeries is a major driver contributing to the market growth. There has been a rise in the demand for high-quality and affordable cosmetic surgical procedures such as non-invasive aesthetic treatments. Further, the report states that the varied regulations for medical devices are among the major challenges faced by the market during the forecast period. Key Vendors - Johnson & Johnson - Lumenis - Syneron Medical Other Prominent Vendors - Abbott Medical Optics - Alcon - Alna Medical System - Angiodynamic - AngioDynamics - AtriCure - biolitec - Boston Scientific - Bovie Medical - Cardiogenesis - Cutera - Cynosure - Dornier MedTech - Ellex - InSightec - IRIDEX - Lightmed - Mederi Therapeutics - Medtronic - Optos - Photocure - PhotoMedex - Quantel Medical - Radiancy - Schwind - Sichuan Jinjiang Electronic Science and Technology - SonaCare Medical - StarMedTec - Ziemer Ophthalmic Systems For more information visit http://www.researchandmarkets.com/research/2jl9cl/global
ELOS: 7.94 (+0.23), BSX: 16.82 (+0.25), JNJ: 94.98 (+1.56), MDT: 70.94 (+1.02), PHMD: 0.52 (+0.06), BVX: 2.10 (+0.21)
Medtronic's Verify System Wins FDA Expanded Use Approval
Zacks Equity Research - Zacks Investment Research - Mon Oct 05, 1:55PM CDT
Medtronic (MDT) is the only known company which manufactures devices like Interstim and Verify systems that facilitate sacral neurostimulator
ICUI: 106.89 (+1.05), NSTG: 15.81 (+0.45), MDT: 70.94 (+1.02), OSUR: 4.59 (+0.09)
Global Bone Grafts and Substitutes 2015-2019 - Demand for Orthopedic Biomaterials
M2 - Mon Oct 05, 9:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gvqp59/global_bone) has announced the addition of the "Global Bone Grafts and Substitutes 2015-2019" report to their offering. The global bone graft and substitute market to grow at a CAGR of 4.31% over the period 2014-2019. Based on type, the global bone graft and substitute market can be segmented into BMP, machine bone allograft, DBM, standard allograft, and others. BMP is beneficial in spinal fusion, joint reconstruction, bone fractures, and bone defects. It also eliminates the need for transplantation of bone from other areas of the body, such as the pelvis. Machine bone allograft uses innovative technology to reshape or mold donor grafts. The report, Global Bone Graft and Substitute Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global bone graft and substitute market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market. In addition to the surging aging population, the incidence rates of osteoarthritis and other types of degenerative disorders are also expected to grow in the future, which will drive the demand for orthopedic biomaterials bone grafts. According to the report, Growing demand for MIS, biologics, and instrumentation has led to more reliable spinal fusion and has reduced patient morbidity. Degeneration of bones and joints, brought about by aging leads to instability and stenosis. This has increased the demand for spinal fusion and joint reconstruction. Further, the report states that the high cost involved in bone grafting surgeries, coupled with inadequate medical reimbursement policies, is affecting the growth of the global bone graft and substitute market. Key vendors - DePuy Synthes - Medtronic - Stryker - Wright Medical Technology - Zimmer Dental Other prominent vendors - AlloSource - Alphatec Spine - Arthrex - Atrium Medical - B. Braun Melsungen - Bacterin International Holdings - Berkeley Advanced Materials - BioMimetic Therapeutics - Cryolife - Exactech - Globus Medical - Graftys SAS - Integra Life Sciences Holdings - Johnson and Johnson - LifeNet Health - Medtronic - Novabone Products - NuVasive - Olympus Biotech - Osteogenics Biomedical - RTI Surgical - Sanofi Aventis - Scient'x/Alphatec Spine - Smith & Nephew - Synthes - Tornier For more information visit http://www.researchandmarkets.com/research/gv...lobal_bone
SNN: 34.52 (-0.77), JNJ: 94.98 (+1.56), MDT: 70.94 (+1.02), GMED: 22.18 (+0.52)
Medtronic's Valiant(R) Thoracic Stent Graft System Demonstrates Durability After Five Years
Thomson Reuters ONE - Mon Oct 05, 8:00AM CDT
Valor II U.S. Study Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms
MDT: 70.94 (+1.02)
Global Radiofrequency Ablation Devices Market Assessment & Forecast: 2015-2019
M2 - Mon Oct 05, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kqtww5/global) has announced the addition of the "Global Radiofrequency Ablation Devices Market Assessment & Forecast: 2015-2019" report to their offering. The global RF ablation devices market is greatly influenced by the segment or application of devices. There are several players operating in multiple segments such as renal denervation, arthroscopy and pain management together. Acquisitions and mergers have further increased competition of companies and the market shows a trend of consolidation of core competencies in radiofrequency ablation technologies. RFA has become the image-guided minimally invasive technique of choice today due to its efficacy, safety, and ease of use. This procedure is also often reserved for patients with comorbidities and those who are inoperable for other reasons and one of the major driving factors for this technology is the fact that a large number of cases are treated as out-patient procedures reducing hospital stay and expenditure. Tumor management and cardiac rhythm management were the largest applications accounting for 60.3% of the market for RF devices across the world. In 2014, revenue generated from devices sold for tumor management across the world accounted for a share of 36.1%. Overall clinical applications of RF energy involve 3 major actions on the body; ablation of cancerous tissue, ablation of obstructive and excessive tissue, denervation or deadening of nerves. Approximately 750,000 new cases of liver cancer are diagnosed each year annually with more than 20,000 being in United States and around 5,000 in the United Kingdom. RF ablation presents one of the best treatment options for solid tumor in liver due to a lack of other alternatives. Lung cancer occurs in over 2.5 million people across the globe and is the leading cause of cancer death with an estimated 1.6 million deaths annually. Although a large percentage of patients are not eligible for surgery, a growing fraction of population is suitable for minimally invasive RF ablation procedure. Stryker offers RF ablation portfolio for both pain management and arthroscopy, similarly Medtronic Inc (and Covidien) together offer a large RF device portfolio targeting general surgery, renal denervation and tumor management. Major players in this market are Medtronic Inc, Johnson & Johnson, Boston Scientific, St. Jude Medical, Stryker, Arthrex, Haylard Health, Angiodynamics, AtriCure, Sutter and Smith & Nephew. Overall the market is quite fragmented and the industry continues to see consolidation in major therapeutic areas such as cardiac ablation and general surgery. Key Topics Covered: Chapter 1 Preface Chapter 2 Pr?cis Chapter 3 Market Dynamics Chapter 4 Radiofrequency Ablation Devices - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019 Chapter 5 Radiofrequency Ablation Devices - Global Market Size Assessment, by Products, Forecast: 2015 - 2019 Chapter 6 Radiofrequency Ablation Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019 Chapter 7 Key Players Analysis: Radiofrequency Ablation Devices Market Share, 2014 (%) Chapter 8 Epilogue Companies Mentioned - AngioDynamics - Arthrex - AtriCure Inc. - Biotronik - Boston Scientific Corporation - Cosman Medical Inc. - Diros Technology - Fcare Systems - Haylard Health Inc. - Hologic (Novasure) - Johnson & Johnson (Biosense Webster & DePuy Mitek) - Medtronic Inc (Covidien PLC) - St. Jude Medical - Stockert - Stryker - Stryker Corporation - Sutter Medizintechnik GmbHTopera (Abbott Laboratories) For more information visit http://www.researchandmarkets.com/research/kqtww5/global
BSX: 16.82 (+0.25), JNJ: 94.98 (+1.56), ABT: 40.63 (+0.74), MDT: 70.94 (+1.02), STJ: 63.10 (+0.62), ATRC: 18.41 (+0.15), HOLX: 37.48 (+0.01), SYK: 96.00 (+1.08)
Medtronic acquires Twelve for undisclosed sum
M2 - Mon Oct 05, 4:38AM CDT
Medical technology company Medtronic (NYSE:MDT) revealed on Friday that it has completed the acquisition of Twelve for an undisclosed value.
MDT: 70.94 (+1.02)
Medtronic Completes Acquisition of Twelve, Inc.
Thomson Reuters ONE - Fri Oct 02, 1:13PM CDT
DUBLIN - October 2, 2015 - Medtronic plc (NYSE: MDT) today announced that it has completed the acquisition of Twelve, Inc. ("Twelve"
, a privately-held medical device company based in Redwood City, CA, focused on the development of a transcatheter mitral valve replacement (TMVR) device. MDT: 70.94 (+1.02)
Are Medtronic's Competitors Finally Catching Up?
Brian Feroldi, The Motley Fool - Motley Fool - Fri Oct 02, 9:47AM CDT
Medical device juggernaut Medtronic is a big player in the world of healthcare, and it holds strong competitive positions in a huge number of diseases including cardiac care, minimally invasive surgery, spinal surgery, and more. One division...
PODD: 29.79 (+1.02), DXCM: 78.66 (-1.46), MDT: 70.94 (+1.02), TNDM: 8.31 (-0.11)
Spinal Implants and Spinal Devices Market - Global Forecast to 2020: Thoracic, Lumbar, Cervical Fusion, Biologics, Motion Preservation, VCFs, Bone Stimulator
M2 - Fri Oct 02, 3:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l93t4t/spinal_implants) has announced the addition of the "Spinal Implants and Spinal Devices Market by Product, Technologies, Minimally Invasive Device & Decompression - Global Forecast to 2020" report to their offering. The market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020 Technological advancements in spine surgery devices, and increasing aging and obese population with increasing number of spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the spinal implants and spinal devices market. However, the stringent product approval process, uncertainty in reimbursement, and high cost of treatment procedures are some of the prime factors restraining the growth of this market. Furthermore, lack of adequate physician and patient awareness/education about newly developed treatment procedures and technologies and high pricing pressure on market players are other factors hampering market growth. Emerging markets, including China, India, South Korea, and Brazil are attractive markets for companies engaged in the development and distribution of spinal implants and spinal devices. Rising government healthcare expenditure, growing income levels, presence of a large patient population, and rising obesity cases in these countries are some of the key factors propelling the demand for spinal implants and spinal devices in these emerging markets. As of 2014, Medtronic, plc (U.S.) held the leadership position in the global spinal implants and spinal devices market. Over the past three years, the company adopted product innovation and new product launches as its key business strategy to ensure its dominance in this market. DePuy Synthes (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V. (Netherlands), K2M Group Holdings, Inc. (U.S.), LDR Holding Corporation (U.S.) are some of the other key players in this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Spinal Implants and Spinal Devices Market, By Product 7 Spinal Implants and Spinal Devices Market, By Technology 8 Spinal Implants and Spinal Devices Market, By Type of Surgery 9 Spinal Decompression Devices Market, By Type of Procedure 10 Spinal Implants and Spinal Devices Market, By Region 11 Competitive Landscape 12 Company Profiles - Alphatec Spine Inc. - Depuy Synthes - Globus Medical, Inc. - K2M Group Holdings, Inc. - Medtronic, PLC - Nuvasive, Inc. - Orthofix International N.V. - Stryker Corporation - Zimmer Biomet Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/l9...l_implants
ATEC: 0.33 (-0.01), ZBH: 94.89 (+0.90), LDRH: 36.98 (+0.84), MDT: 70.94 (+1.02), GMED: 22.18 (+0.52), OFIX: 33.18 (+0.05), NUVA: 52.21 (+0.14), KTWO: 19.83 (-0.25), SYK: 96.00 (+1.08)
Research and Markets: Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis Featuring Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter International
Business Wire - Fri Oct 02, 3:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c2h7sm/global_medical) has announced the addition of the "Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis" report to their offering.
JNJ: 94.98 (+1.56), GE: 27.77 (+0.48), MDT: 70.94 (+1.02)
Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis Featuring Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter Internationa
M2 - Fri Oct 02, 3:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/488wjw/global_medical) has announced the addition of the "Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis" report to their offering. The global medical device market is expected to grow at a CAGR of 4.9% from 2015 to 2020. The major drivers of this market are increasing per capita income, availability of medical insurance, and increasing health-related infrastructure. Asia Pacific (APAC) is expected to lead the global medical device market. Technological advancement, growing population, and increasing health-related infrastructure are anticipated to drive the Asia Pacific market. The author has analyzed the global medical device market by region and has come up with a comprehensive research report, "Global Medical Device Market 2015-2020: Trend, Profit, and Forecast Analysis". This report provides an analysis of the global medical device market, including the market trends, growth opportunities, key drivers, and emerging trends in the market. Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter International Inc. are some of the major suppliers of medical devices to various customers of the industry. Key Topics Covered: 1. Executive Summary 2. Market Definition and Scope 3. Market Overview 4. Macroeconomic Trend 5. Market Trends 6. Competitive Landscape 7. Macroeconomic Forecast 8. Market Forecasts 9. Emerging Trends 10. Growth Opportunity 11. Conclusions For more information visit http://www.researchandmarkets.com/research/48...al_medical
JNJ: 94.98 (+1.56), GE: 27.77 (+0.48), MDT: 70.94 (+1.02)
Medtronic Set to Possibly Pullback After Yesterday's Rally of 2.18%
Comtex SmarTrend(R) - Thu Oct 01, 4:29PM CDT
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $66.35 to a high of $68.48. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $68.01 on volume of 11.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 70.94 (+1.02)
